GENFIT: new market research data highlight potential of elafibranor in PBC

    NEXT STORY
    Atreca to Participate at Upcoming Virtual Investor Conferences
    PREV STORY
    Plus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BriaCell CEO to Present at 3rd Annual Next-Gen Immuno-Oncology Congress in June

    author_avatar
    NASDAQ Market News

    Retrophin Announces Publication of Phase 2 DUET Study of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis in the Journal of the American Society of Nephrology

    DUET publication highlighted during Best of ASN Journals session at ASN Kidney Week 2018 ...

    author_avatar
    NASDAQ Market News

    AB Science will hold an Investor & Analyst conference on masitinib in Amyotrophic Lateral Sclerosis (ALS) in New York, USA, on June 13, 2016

    Following recommendation by the European Medicines Agency (EMA) to file masitinib for conditional marketing ...

    author_avatar
    NASDAQ Market News